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Abstract: 26 
Background: Cancer screening provides an opportunity to increase awareness of cancer 27 
preventive lifestyle behaviors such as non-smoking, physical activity, low alcohol consumption 28 
and a healthy diet. We tested the effect of standardized, individually-tailored written feedback 29 
and a standard leaflet on one-year lifestyle behaviors in a colorectal cancer (CRC) screening 30 
setting.  31 
Methods: Three-thousand-six-hundred-and-forty-two men and women aged 50-74 years invited 32 
to sigmoidoscopy screening were randomly assigned to; i) standardized, individually-tailored 33 
written feedback (TF); ii) standard leaflet (SL) for cancer preventive lifestyle behaviors; or iii) 34 
control. Participants were mailed two self-reported lifestyle questionnaire (LSQ) one year apart. 35 
The TF intervention was based on the prescreening LSQ answers. We analyzed differences (with 36 
95% confidence intervals (CI)) by comparing prescreening to one-year follow-up of single cancer 37 
preventive factors and the number of cancer preventive lifestyle behaviors (range 0-4) between 38 
the groups by multivariable logistic regression and ANCOVA analyses.  39 
Results: One-thousand-and-fifty-four screening participants without neoplastic findings (29% of 40 
those invited to screening) were included in the present study. Participants in the TF group 41 
increased their number of cancer preventive lifestyle behaviors significantly compared to those in 42 
the control group by 0.11 (95% CI 0.02 to 0.19). Overweight/obese individuals in the TF group 43 
had a -0.84 kg (95% CI -1.47 to -0.22) larger reduction in body weight compared to the control 44 
group.  45 
Conclusions: Individually-tailored written feedback at sigmoidoscopy screening led to small 46 
improvements in cancer preventive behaviors.  47 
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Impact: CRC screening is a suitable setting for increasing awareness of cancer preventive 48 
behavior. 49 
Keyword: lifestyle, behavior, intervention, score, change, prevention, colorectal cancer 50 
screening.  51 
 52 
  53 
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Introduction: 54 
The context of cancer screening provides an opportunity for a teachable moment to increase 55 
participants’ awareness of cancer prevention with a healthy lifestyle (1). Cancer screening 56 
programs have not yet fully utilized this opportunity (2,3). It is particularly important to increase 57 
lifestyle awareness at screening for cancers that are closely related to lifestyle such as colorectal 58 
neoplasia (4-7), as well as recurrent adenomas (8,9). Raising awareness of the importance of a 59 
healthy lifestyle at CRC screening is also particularly relevant in light of evidence that CRC 60 
screening participation may reduce participants’ motivation to make healthy lifestyle choices 61 
(10,11).  62 
An automatized written feedback letter delivered in a screening context would be a feasible low-63 
cost strategy for increasing screening participants’ awareness of their own lifestyle. Two separate 64 
British intervention studies within CRC screening programs have shown beneficial effects of 65 
individually-tailored written advice on consumption of fruit and vegetables in screening 66 
participants in the short (six weeks) (12) and longer term (six months) (13). Because only long-67 
lasting beneficial lifestyle behaviors may impact chronic disease risk, such intervention effect 68 
should be investigated by an extended follow-up.  69 
The present study aimed to investigate the effect of i) standardized, individually-tailored written 70 
feedback and ii) a standard leaflet for cancer preventive lifestyle on one-year follow-up of 71 
lifestyle behaviors in the context of CRC sigmoidoscopy screening.  72 
Materials and Methods 73 
Study design and participants 74 
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The present study is a sub-study within the Bowel Cancer Screening in Norway (BCSN) trial, a 75 
randomized trial piloting a national CRC screening program. The BCSN is carried out in two 76 
geographically defined areas in south-eastern Norway, Moss representing a more rural area and 77 
Bærum representing a more urban area. Men and women aged 50-74 years are included (14). 78 
From November 2014 to September 2015, 3642 individuals invited to sigmoidoscopy were 79 
additionally invited to complete a two-page lifestyle questionnaire (LSQ). We sent the 80 
questionnaire along with the screening invitation to be completed prior to the screening 81 
examination (prescreening LSQ). The individuals were randomized (1:1:1) at invitation based on 82 
the unique Norwegian social security number to one of the three groups: i) standardized, 83 
individually-tailored written feedback (TF); ii) standard leaflet (SL) for cancer preventive 84 
lifestyle; or iii) control. A computer program carried out the randomization automatically. This 85 
randomization was blinded to the researchers and designed by the IT developer, following the 86 
consort guidelines (supplementary material 4). We mailed a second LSQ to the prescreening 87 
responders 12 months after the mailing of the prescreening LSQ. The outcome change in 88 
lifestyle was assessed by the follow-up LSQ. A paper version of the LSQ was included in the 89 
screening invitation letter. It was also possible to complete the LSQs in an online version 90 
available by personal login via a link provided in the invitation. No reminder was sent to non-91 
responders of the questionnaire. 92 
Lifestyle questionnaire (LSQ)  93 
The LSQ consisted of questions used in previous national surveys (15,16) and the Norwegian 94 
Colorectal Cancer Prevention study (11,17). The participants were asked about demographic 95 
factors as well as lifestyle behaviors.  96 
Demographic factors included ethnicity - dichotomized as native (Norway) or non-native (any 97 
other country), marital status - dichotomized as married/cohabiting or non-married/non-98 
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cohabiting (or single), education length (primary school, high school, or a minimum of two years 99 
at university/college) and working status - dichotomized as working or not working (including 100 
retired, unemployed, homemakers and disabled/on rehabilitation).  101 
Height was assessed by whole centimeters and weight as whole kilograms. 102 
The lifestyle behaviors included smoking status, dichotomized into current smokers (daily and 103 
occasional) and non-smoker (former or never smokers). Physical activity (times/week of 30 min 104 
of activity) was calculated by adding the responses on frequency to the two questions on 105 
physical activity “without sweating or shortness of breath” and “with sweating or getting short of 106 
breath”. Frequency ranged from ‘never’ to ‘more than seven times/week’. Consumption of 107 
alcoholic beverages (glasses/week) was calculated by frequency of intake multiplied by the 108 
number of glasses usually consumed. Consumption of fruit, berries and vegetables was 109 
calculated as a sum of reported consumption of 1) fruits and berries, 2) raw vegetables, and 3) 110 
boiled vegetables (portions/day). Consumption of red and processed meat for dinner was 111 
calculated as a sum of reported frequency consumption of 1) steak, pork chops or similar, 2) 112 
hamburgers or other dishes with minced meat, and 3) sausages (portions/week). Six frequency 113 
alternatives ranging from ‘seldom/never’ to ‘more than three portions/day’ were provided as 114 
response options for the dietary questions.  115 
Based on the following factors: smoking habits, physical activity, and consumption of alcoholic 116 
beverages, fruit, berries and vegetables we created a scale for the number of cancer preventive 117 
lifestyle behaviors (Table 1). The number of cancer preventive lifestyle behaviors ranged from 118 
zero to four. Each of the single lifestyle factors was dichotomized to reflect adherence to health 119 
recommendations (18-20). Change in weight was used as a separate outcome and not included in 120 
the scale for number of cancer preventive lifestyle behaviors. Body mass Index (BMI, kg/m
2
) 121 
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was calculated to identify individuals who were not following the health recommendations on 122 
weight (≥25 kg/m2).  123 
 124 
Intervention 125 
The control group did not receive any intervention or information on CRC prevention. 126 
One to four weeks after completion of the prescreening LSQ, responders in the SL group 127 
received the Norwegian Cancer Society’s one-page leaflet, “Good habits for a healthier life” 128 
with lifestyle advice for low cancer risk (supplementary material 1) by mail. The leaflet was 129 
mailed either before or after the screening examination. 130 
Similarly, one to four weeks after completion of the prescreening LSQ, responders in the TF 131 
group received a two-to-three-page letter by mail from the research team with a standardized, 132 
individually-tailored written feedback letter based on their answers to the prescreening LSQ. The 133 
letter addressed five lifestyle factors; smoking, consumption of alcoholic beverages, 134 
consumption of fruit, berries and vegetables, physical activity and body weight. The behaviors 135 
reported by the participant were compared to health recommendations. The participant was 136 
praised if meeting the recommendations. If the reported behaviors did not meet the 137 
recommendations, the individual was encouraged to change their behavior to meet the 138 
recommended levels. This could be; “You answered that you rarely or never eat fruit, berries and 139 
vegetables. This is less than recommended. The recommendation is to eat at least five 140 
servings/day. One serving is approximately 100g. This equals e.g. a small bowl of salad, a carrot 141 
or a medium sized fruit”. All participants in the TF group also received the Norwegian Cancer 142 
Society’s one-page leaflet (Supplementary material 1 and 2).  Subjects in both the TF and SL 143 
groups who reported current smoking additionally received the Norwegian Cancer Society’s 144 
leaflet “Stop smoking without gaining weight” (supplementary material 3).  145 
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 146 
Screening 147 
The sigmoidoscopy screening result was defined as positive if one of the following was detected 148 
or suspected: 1) any polyp ≥ 10 mm in diameter, 2) any adenoma with villous histology or high-149 
grade dysplasia, 3) ≥ 3 adenomas or 4) cancer. Participants with a positive screening were 150 
referred to a follow-up colonoscopy. The final screening result in the present study was one of 151 
the following: 1) negative screening, 2) other findings or 3) neoplasia based on the 152 
sigmoidoscopy and colonoscopy. 153 
Exclusion criteria 154 
Participants were excluded from screening due to medical reasons (e.g., severe heart, lung or 155 
liver diseases, cancer with life expectancy less than one year), previous CRC, relocating out of 156 
the screening municipalities or previous colonoscopy in the last 12 months. Furthermore, 157 
participants were excluded from the present study if not completing the prescreening LSQ or if 158 
the completion date was not possible to determine. Participants who completed the prescreening 159 
LSQ after the screening examination, or who completed the one-year follow-up LSQ <10 or >14 160 
months after prescreening LSQ were also excluded. Individuals with any adenomas or cancer 161 
findings at screening were excluded from the present study (Figure 1) to minimize potential bias 162 
of lifestyle change caused by being diagnosed with adenomas or CRC. This adds comparability 163 
between the present and earlier studies, e.g. Robb et at. 2010 164 
 165 
Statistical analyses 166 
We used t-tests to evaluate the changes in lifestyle between prescreening and one-year follow-up 167 
within each group. McNemar’s test was used similarly for changes in smoking status. When 168 
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examining differences in changes in lifestyle variables between the intervention groups and the 169 
control group at follow-up, we used an analysis of covariance for the continuous variables, and a 170 
multivariable logistic regression model for smoking. The 95% confidence interval (CI) was also 171 
calculated The statistical models were adjusted for sex, age at invitation, education length, 172 
working status, ethnicity, marital status, screening center (Moss or Bærum Hospital), and time 173 
between completion of prescreening and follow-up questionnaires. The models were additionally 174 
adjusted for the prescreening value of the examined variable and prescreening values for weight, 175 
and the lifestyle variables; smoking status, level of physical activity, consumption of alcoholic 176 
beverages, fruit and vegetables, and red and processed meat and fish. Self-reported chronic 177 
disease was not included in the final model, because the preliminary models adjusting for this 178 
variable did not differ from the presented results. We conducted analyses stratified by gender. We 179 
also compared change in lifestyle between the TF and SL -groups. Furthermore, we completed 180 
statistical analyses including only individuals who did not adhere to single health 181 
recommendations or who had a number of cancer preventive lifestyle behaviors ≤ 2 at 182 
prescreening.  183 
Sample size estimates: We based the power calculation on predicted difference in self-reported 184 
one year change in intake of fruit, berries and vegetables between the standardized, individually-185 
tailored written feedback and the control group, which we expected to be 0.26 (SD 1.53) 186 
portions/day (80% power, P=0.05) (21). We estimated 540 subjects in each of the three groups to 187 
be an adequate number for analyses. We invited 3642 subjects to participate.  188 
The primary analyses were based on intention-to-treat, where if missing the one-year follow-up 189 
LSQ the values in the prescreening LSQ was carried forward. Similarly, if answered the one-year 190 
follow-up LSQ but values were missing, the baseline values were carried forward. Secondary 191 
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analyses were based on complete case analyses, meaning that individuals with missing one-year 192 
follow-up LSQ or missing values in one or several variables were excluded from the analyses.  193 
 The analyses were carried out using STATA software, version 14.1 (Stata Corp., College 194 
Station, Texas, USA). 195 
Results 196 
Overall, 3642 individuals were invited, and 1433 (39%) participated in sigmoidoscopy screening 197 
and completed the prescreening LSQ. Of these, 1054 (75%) completed the prescreening LSQ 198 
before the screening and had no neoplastic findings: 308 in the TF, 392 in the SL and 354 in the 199 
control group (Figure 1). These were used for the primary analyses based on intention to treat. 200 
The demographic characteristics of the three groups at prescreening are shown in Table 2. More 201 
individuals in the SL group had a high-level education compared to the TF and control group.  202 
Table 3 shows lifestyle characteristics at prescreening and one-year changes in the TF, SL and 203 
control groups and adjusted differences in lifestyle changes during follow-up. There were no 204 
differences in lifestyle factors at prescreening between the groups. Individuals in the SL group 205 
reduced their alcohol consumption significantly by -0.54 glasses/week (95%CI -0.94 to -0.14) 206 
compared to the control group. Individuals in the TF group increased their number of cancer 207 
preventive lifestyle behaviors significantly by 0.11 (95% CI 0.02 to 0.19) compared to the control 208 
group (Table 3). Analyses stratified by gender showed that only men in the SL group 209 
significantly decreased their consumption of alcoholic beverages compared to controls -0.91 210 
glasses/week, (95% CI -1.56 to -0.26). Women in the TF group significantly increased their 211 
physical activity by 0.51 times/week (95% CI (0.05 to 1.98) compared to controls. Only men in 212 
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the SL group significantly increased their number of cancer preventive lifestyle behaviors by 0.13 213 
(95% CI 0.01 to 0.24) compared to controls (See supplementary material 5, table 1). 214 
Lifestyle characteristics and one-year changes for individuals who did not adhere to single health 215 
recommendations and those with a number of cancer preventive lifestyle behavior ≤ 2 at 216 
prescreening are shown in Table 4. Among participants with a BMI ≥25 kg/m2, individuals in the 217 
TF group reduced their weight significantly by -0.84 kg (95% CI -1.47 to -0.22) compared to the 218 
controls at one-year follow-up. In the SL group, participants with an alcohol consumption higher 219 
than recommended had a significant decrease in consumption by  220 
-4.98 glasses/week (95% CI -7.83 to -2.13) compared to the controls at one-year follow-up (Table 221 
4).  222 
When comparing the TF with the SL group, a significantly higher increase in fruit and vegetable 223 
intake was observed in the TF group; 0.18 portions/day (95% CI 0.01 to 0.34) (See 224 
supplementary material 5, table 2). 225 
The proportion of non-responders to the one-year follow-up LSQ differed between the three 226 
groups, being 100/308 (32%) in the TF, 90/392 (22%) in the SL and 85/354 (24%) in the control 227 
group (Figure 1). Non-responders to the follow-up LSQ were younger (mean age 62.8, 63.9 and 228 
62.8 years) compared to the responders (mean age 65.9, 65.2 and 64.7 years) in the TF, SL and 229 
control groups, respectively. Prescreening lifestyle variables and screening result did not differ 230 
between the follow-up LSQ responders and non-responders. The secondary results by complete 231 
case analyses, based on the 779 participants who completed both the prescreening LSQ and the 232 
one-year follow-up LSQ showed similar trends as the primary intention-to-treat analyses. The 233 
improvement in the number of cancer preventive lifestyle behaviors was some larger in the 234 
complete case analyses than in the intention-to-treat analyses (see supplementary material, 5, 235 
 12 
 
table 3 and 4). The improvement in fruit and vegetables intake in the TF compared to the control 236 
group was significant only in the complete case analyses. 237 
Discussion 238 
In this randomized trial in a CRC screening setting, we found that standardized, individually-239 
tailored written feedback (TF) led to small improvements at one-year follow-up for cancer 240 
preventive behaviors among participants with no neoplastic findings. There was a low overall 241 
questionnaire response rate at prescreening (39%).The non-response rate to the one-year follow-242 
up LSQ was higher in the TF group (32%) compared to the SL (22%) and control (24%) –groups. 243 
However, similar trends were observed for the intention-to-treat analyses (including non-244 
responders to one-year follow-up LSQ) and complete-case analyses (excluding non-responders to 245 
one-year follow-up LSQ).  246 
To the best of our knowledge, this is the first letter-based lifestyle intervention study with follow-247 
up time longer than six months in a population-based CRC screening context. The few studies on 248 
lifestyle intervention in a CRC screening setting have suggested that an individually tailored 249 
approach  is more effective than delivery of standard leaflets (12,13,22,23). This has been 250 
observed as increased consumption of fruit and vegetables in both short (six weeks) (12) and 251 
longer term (six months) (13). The short-term trial (six weeks) intervened on fruit and vegetable 252 
intake only. That study differed from the present study by including individuals who voluntarily 253 
signed up to receive more information about healthy diet (12), while the present study included a 254 
random sample of sigmoidoscopy invitees. The six-month-follow-up trial (13) showed that the 255 
individually tailored intervention had an effect on fruit and vegetable consumption similar to our 256 
study. An intervention trial including only individuals diagnosed with colorectal adenomas at 257 
CRC screening found  personalized advice letters and face-to-face contact to increase fiber intake 258 
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after three months (23). Also in a non-screening setting, eight months of telephone counseling 259 
and a tailored letter intervention after removal of adenomatous polyps increased physical activity 260 
level, reduced intake of red meat and increased an overall score on lifestyle (22). These studies 261 
may indicate a higher success of lifestyle interventions in high-risk individuals compared to our 262 
population, as earlier suggested (24), although the interventions used were also more intense 263 
(face-to-face contact, telephone counseling) than the present study.  264 
Some limitations have to be acknowledged in interpreting the present results. We did not have 265 
information about the participants’ pre-study awareness of lifestyle recommendations or their 266 
knowledge of the association between lifestyle and risk of CRC at prescreening. However, this 267 
might be a minor problem, as previous studies have not observed any effect of awareness of 268 
lifestyle recommendations on change in lifestyle (13). Attitudes to lifestyle change were not 269 
assessed in the present study and could be a confounding variable. The findings are only 270 
generalizable to those attending CRC screening and completing a LSQ. People attending cancer 271 
screening willing to complete questionnaires might be more motivated towards cancer preventive 272 
behavior or lifestyle changes than the general population and non-participants. The sample size 273 
was smaller than estimated by the power calculations, which resulted in the study being 274 
underpowered. We were unable to analyze the independent effect of the standardized, 275 
individually-tailored written feedback without the standard leaflet for cancer preventive lifestyle, 276 
because these were both sent to the TF and SL group. Furthermore, chance findings cannot be 277 
ruled out as a large number of statistical tests were carried out. The results should be interpreted 278 
with caution and as indicative findings that should be tested in a fully powered trial.  279 
A strength of the present study was the relatively long-term follow-up period. The intervention 280 
with a multiple risk factor approach may be more effective on overall lifestyle change compared 281 
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to an approach with one or two individual lifestyle factors (25,26). Furthermore, being a 282 
population-based randomized trial increases the generalizability of the results to population based 283 
screening programs.  284 
A minimal intervention such as the TF or SL in this study might not be adequate to enhance 285 
lifestyle behaviors or reinforce motivation to change lifestyle behaviors over time. However, it 286 
may increase awareness of the importance of lifestyle behavior to lower CRC risk when delivered 287 
at CRC screening (27). To have an impact on population health, the lifestyle improvement has to 288 
be long lasting. To date, there are no intervention trials with longer than one-year follow-up 289 
within CRC-screening. Future trials should therefore test the effect of repeated reminders of 290 
lifestyle recommendations on lifestyle behavior e.g. by standard leaflets or a smartphone app. 291 
Furthermore, it should be investigated if intervention materials should be tailored to gender and 292 
educational level. A previous Norwegian study showed that CRC screening increased the 293 
occurrences of lifestyle related diseases among individuals with low educational levels but not for 294 
people with higher levels of education (28). The present study indicates that the effect of giving a 295 
leaflet on healthy behaviors at CRC screening may be almost as effective as standardized, 296 
individually-tailored written feedback in promoting favorable lifestyle changes. Future studies are 297 
necessary to separate the impact of individual and general feedback. 298 
Conclusion 299 
A low-cost, minimal intervention using standardized, individually-tailored written feedback and a 300 
standard leaflet for cancer preventive behaviors given in a CRC screening context led to small 301 
improvement in cancer preventive behaviors. The intervention appeared to be most effective in 302 
over weight individuals.  303 
 304 
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Table 1. Number of cancer preventive lifestyle behaviors and cutoff for each cancer preventive behavior  
   
 Prescreening Follow-up 
Smoking   
   Non-smoking  1 1 
   Smoking 0 0 
   
Physical activity,    
   ≥ 30 min times/week 1 1 
    < 30 min times/week 0 0 
   
Alcoholic beverages, mean glasses/week   
   ≤ 14 for ♂, ≤ 7 for ♀) 1 1 
   > 14 for ♂, > 7 for ♀) 0 0 
   
Fruits & vegetables, mean portions/day   
   ≥5 a day 1 1 
   < 5 a day 0 0 
   
Number of cancer preventive lifestyle 
behaviors 
1-4 1-4 
 421 
Table 2. Demographic characteristic.  
A randomized trial of tailored lifestyle feedback in a sub study of the sigmoidoscopy arm of the bowel cancer screening in 
Norway: a pilot study. TF = standardized, individually-tailored written feedback, SL= standard leaflet and controls 
N=1054.(Intention-to-treat analyses),  
 TF  (n=308) 
 
SL (n=392)  
 
Controls (n=354)  
 
Age    
   Mean (SD), years 64.1 (6.9) 64.9 (7.0) 63.8 (6.8) 
    
Time between sigmoidoscopy and one-year follow-up LSQ    
   Mean (SD), days 345,6 (29.4) 341.4 (25.6) 346.6 (33.9) 
    
Sex (%)    
   Female 53 50 52 
    
Center (%)    
   Moss 72 39 74 
   Bærum 28 61 26 
    
Working status (%)*    
   Working 48 47 49 
   Not working 48 49 49 
    
Marital status (%)*    
   Non-married/ non-cohabiting (or single) 19 20 18 
   Married/cohabiting 79 77 80 
    
Education length (%)*    
   Primary school 18 12 16 
   High school 39 39 43 
   University/≥2 years at college 41 46 37 
    
Ethnicity (%)*    
   Norwegian 92 92 95 
   Not Norwegian  5 7 3 
 19 
 
N=1054, who answered the lifestyle questionnaire at prescreening before sigmoidoscopy and without neoplasia. *The percent 
might not add up to 100% due to missing data. 
 422 
Table 3. Changes in cancer preventive factors. 
A randomized trial of tailored lifestyle feedback in a sub study of the sigmoidoscopy arm of the bowel cancer screening in 
Norway: a pilot study. TF standardized, individually-tailored written feedback, SL= standard leaflet and controls. N=1,054 
(Intention-to-treat analyses) 
 TF (n=308) SL (n=392) Control (n=354) 
    
Non-smoker (%)    
Prescreening 83.4 87.5 83.3 
one-year follow up 86.6 88.5 86.8 
Change¤ ns ns ns 
Adjusted one-year outcome compared to the controls, odds ratio 
(95% confidence interval (CI)) 
2.38 (0.56 to 
10.2) 
1.85 (0.41 to 8.28) 1.00 (ref) 
    
Weight, mean (kg)    
Prescreening, (S.D) 79.6 (14.7) 78.7 (14.9) 80.8 (15.1) 
one-year follow-up, (S.D) 79.6 (14.8) 78.6 (15.0) 80.8 (15.2) 
Change, (95% CI) -0.08 (-0.37 to 
0.22) 
-0.03 (-0.28 to 
0.22) 
0.17(-0.07 to 
0.41) 
Adjusted one-year outcome compared to the controls,  (95%CI) -0.27 (-0.73 to 
0.19) 
-0.39 (-0.83 to 
0.06) 
(ref) 
    
Physical activity, mean 30 min times/week    
Prescreening, (S.D) 4.2 (2.8) 4.7 (3.0) 4.1 (2.9) 
one-year follow-up, (S.D) 4.2 (2.7) 4.7 (3.0) 4.0 (2.8) 
Change, (95% CI) -0.01 (-0.22 to 
0.21) 
-0.06 (-0.27 to 
0.14) 
-0.05 (-0.26 to 
0.16) 
Adjusted one-year outcome compared to the controls,  (95%CI) 0.14 (-0.19 to 
0.48) 
0.04 (-0.29 to 
0.37) 
(ref) 
    
Alcoholic beverages, mean glasses/week    
Prescreening, (S.D) 4.2 (15.4) 4.4 (9.1) 3.8 (5.0) 
one-year follow-up, (S.D) 4.4 (15.6) 4.0 (5.7) 4.0 (5.2) 
Change, (95% CI) 0.23 (-0.12 to 
0.57) 
-0.41 (-1.18 to 
0.35) 
0.18 (-0.09 to 
0.44) 
Adjusted one-year outcome compared to the controls,  (95%CI) -0.27 (-0.68 to 
0.14) 
-0.54 (-0.94 to -
0.14) 
(ref) 
    
Fruits & vegetables, mean portions/day    
Prescreening, (S.D) 2.3 (1.3) 2.3 (1.3) 2.2 (1.4) 
one-year follow-up, (S.D) 2.4 (1.5) 2.3 (1.3) 2.2 (1.4) 
Change, (95% CI) 0.11 (0.00 to  
0.23) 
-0.04 (-0.12 to 
0.05) 
0.02 (-0.11 to -
0.14) 
Adjusted one-year outcome compared to the controls,  (95%CI) 0.12 (-0.05 to 
0.28) 
-0.01 (-0.16 to 
0.15) 
(ref) 
    
╬ Number of cancer preventive lifestyle behaviors, mean 
number 
   
Prescreening (S.D) 2.0 (0.7) 2.1 (0.7) 2.0 (0.7) 
one-year follow-up (S.D) 2.1 (0.7) 2.1 (0.6) 2.0 (0.7) 
Change (95% CI) 0.02 (-0.04 to 
0.09) 
-0.03 (-0.08 to 
0.03) 
-0.04 (-0.10 to 
0.02) 
Adjusted one-year outcome compared to the controls,  (95%CI) 0.11 (0.02 to 
0.19) 
0.06 (-0.02 to 
0.14) 
(ref) 
Paired t-test was used to test mean changes and 95% confidence intervals (95% CI), ¤McNemar test was used to test for changes 
in smoking status, within the groups (TP, SL, control), ns =nonsignificant. Intention-to-treat analyses used. 
* In the adjusted models differences in change of lifestyle between TP vs. control and SL vs. control were tested.  
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A logistic regression model was used for smoking and ANCOVA for the other lifestyle variables. The adjusted models were 
controlled for: age, sex, screening center, ethnicity, marital status, working status, education length, prescreening weight and 
prescreening value of the dependent variable along with prescreening value of the other lifestyle variables.  
╬ the number of cancer preventive lifestyle behaviors were adjusted for age, sex, screening center, ethnicity, working status, 
education length, prescreening weight and the prescreening number of cancer preventive lifestyle behaviors.  
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Table 4. Changes in cancer preventive factors for individuals who did not adhere to health recommendations at 
prescreening. A randomized trial of tailored lifestyle feedback in a sub study of the sigmoidoscopy arm of the bowel cancer 
screening in Norway: a pilot study.  TF = standardized, individually-tailored written feedback SL= standard leaflet and controls. 
(Intention-to-treat analyses) 
 TF SL Controls 
    
Smokers prescreeningN=156 n=51 n=49 n=56 
Non-smokers, prescreening, n 0 0 0 
Non-smokers, one-year follow-up, n 7 4 6 
  Change p=0.02 p=0.13 p=0.03 
Adjusted one-year outcome compared to the controls, by logistic 
regression, odds ratio (95% confides interval (CI)) 
2.33 (0.31-17.5) 0.50 (0.03-7.55) 1.00 (ref) 
    
Weight, mean (kg), N=620 n=178 n=217 n=225 
prescreening, (S.D) 87.5 (12.6) 87.0 (12.1) 88.0 (12.5) 
one-year follow-up, (S.D) 87.1 (12.8) 86.9 (12.5) 88.1 (12.6) 
Change -0.40 (-0.85 to 
0.04) 
-0.14 (-0.51 to 
0.23) 
0.12 (-0.17 to 
0.40) 
Adjusted one-year outcome compared to the controls (95% CI)  -0.84 (-1.47 to -
0.22) 
-0.61 (-1.22 to 
0.00) 
(ref) 
    
Physical activity, mean 30 min times/weekN=743 n=229 n=257 n=257 
prescreening, (S.D) 3.1 (1.7) 3.2 (1.6) 2.8 (1.7) 
one-year follow-up, (S.D) 3.5 (2.3) 3.5 (2.2) 3.2 (2.2) 
Change 0.38 (0.17 to 
0.59) 
0.32 (0.10 to 
0.54) 
0.38 (0.19 to 
0.58) 
Adjusted one-year  outcome compared to the controls (95% CI) 0.03 (-0.33 to 
0.39) 
-0.11 (-0.47 to 
0.25) 
(ref) 
    
Alcoholic beverages, mean glasses/weekN=77 n=22 n=29 n=26 
prescreening, (S.D) 11.8 (3.9) 12.7 (5.2) 15.9 (7.8) 
one-year follow-up, (S.D) 10.3 (4.3) 9.5 (5.2) 15.6 (8.5) 
Change -1.52 (-3.44 to 
0.40) 
-3.20 (-5.40 to -
1.00) 
-0.27 (-1.29 to 
0.75) 
Adjusted one-year  outcome compared to the controls (95% CI) -0.83 (-3.82 to 
2.16) 
-4.98 (-7.83 to -
2.13) 
(ref) 
    
Fruits & vegetables, mean portions/dayN=941 n=275 n=350 n=316 
prescreening, (S.D) 2.2 (1.1) 2.2 (1.1) 2.1 (1.1) 
one-year follow-up, (S.D) 2.3 (1.4) 2.2 (1.1) 2.2 (1.3) 
Change 0.13 (0.02 to  
0.25) 
0.00 (-0.08 to 
0.08) 
0.08 (-0.03 to 
0.19) 
Adjusted one-year  outcome compared to the controls (95% CI) 0.12 (-0.04 to 
0.28) 
-0.01 (-0.16 to 
0.15) 
(ref) 
    
Number of cancer preventive lifestyle behaviors  ≤ 2, mean ╬ 
N=641 
n=192 n=235 n=214 
prescreening (S.D)  1.8 (0.4) 1.8 (0.4) 1.7 (0.5) 
one-year follow-up, (S.D) 1.9 (0.5) 1.9 (0.5) 1.8 (0.6) 
Change 0.11 (0.05 to 
0.17) 
0.09 (0.03 to 
0.15) 
0.08 (0.02 to 
0.13) 
Adjusted one-year  outcome compared to the controls (95% CI) 0.08 (-0.00 to 
0.17) 
0.03 (-0.06 to 
0.11) 
(ref) 
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Paired t-test was used to test mean changes and 95% confidence intervals (95% CI), ¤McNemar test was used to test for changes 
in smoking status, within the groups (TP, SL, control), ns =nonsignificant. Intention-to-treat analyses used. 
* In the adjusted models differences in change of lifestyle between TP vs. control and SL vs. control were tested. A logistic 
regression model was used for smoking and ANCOVA for the other lifestyle variables. The adjusted models were controlled for: 
age, sex, screening center, ethnicity, marital status, working status, education length, prescreening value of the dependent 
variable, prescreening weight along with prescreening value of the other lifestyle variables.  
╬ the number of cancer lifestyle preventive behaviors were adjusted for age, sex, screening center, ethnicity, working status, 
education length, prescreening weight and the prescreening number of cancer preventive lifestyle behaviors. 
 424 
Figure legends 425 
Figure 1. Flow-chart of participant recruitment and randomization. 426 
 427 
Assessed for eligibility  
Standardized, individually-tailored feedback (TF) (n=1199), Standard Leaflet (SL) (n=1239), controls (n=1204) 
 
dead (n=91), emigrated (n=21), medical reasons (n=42), moved (n=3) 
did not respond (n=1670), 
did not complete the prescreening LSQ but attended sigmoidoscopy (n=338) 
completed the prescreening LSQ but did not attend sigmoidoscopy (n=44) 
Did not complete 1-year follow-up LSQ (n=90) 
Excluded: 
Completed the prescreening LSQ after screening 
(n=16) 
Completed the 1-year follow-up LSQ < 10 month or 
>14 months after prescreening (n=42) 
Diagnosed with neoplasia (n=53) 
 
Excluded: 
Completed the prescreening LSQ after screening 
(n=12) 
Completed the 1-year follow-up LSQ < 10 month or 
>14 months after prescreening (n=30) 
Diagnosed with neoplasia (n=83) 
 
Complete case analysis (n=208) Complete case analysis (n=302) Complete case analysis  (n=269) 
Excluded: 
Completed the prescreening LSQ after screening 
(n=19) 
Completed the 1-year follow-up LSQ < 10 month or 
 >14 months after prescreening (n=52) 
Diagnosed with neoplasia (n=72) 
SL (n=503) TF (n=451) Controls (n=479) 
Figure 1.  
Intent-to-treat analysis  (n=354) Intent-to-treat analysis (n=392) Intent-to-treat analysis (n=308) 
Did not complete 1-year follow-up LSQ (n=100) Did not complete 1-year follow-up LSQ (n=85) 
